| Serial Number | 90726719 |
| Word Mark | MYOLIVITY |
| Filing Date | Friday, May 21, 2021 |
| Status | 734 - FIFTH EXTENSION - GRANTED |
| Status Date | Wednesday, July 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products, namely, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| Pseudo Mark | MY OLIVETTI |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 18, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, May 25, 2021 | NEW APPLICATION ENTERED |
| Thursday, February 3, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, February 3, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, February 3, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 18, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 2, 2022 | ASSIGNED TO EXAMINER |
| Monday, July 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 28, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, March 28, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, March 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 10, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 10, 2023 | SOU EXTENSION 2 FILED |
| Thursday, March 28, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, March 28, 2024 | SOU EXTENSION 3 FILED |
| Friday, March 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 28, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 22, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 22, 2024 | SOU EXTENSION 4 FILED |
| Tuesday, October 22, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 22, 2024 | SOU EXTENSION 4 GRANTED |
| Sunday, April 6, 2025 | SOU EXTENSION 5 FILED |
| Monday, April 7, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 23, 2025 | SOU EXTENSION 5 GRANTED |
| Wednesday, July 23, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, July 23, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |